Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elismetrep in Acute Migraine
NCT06848075Phase 2Completed
- Sponsor
- Kallyope
- Start
- Mar 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of elismetrep in migraine, sponsored by Kallyope. Started Mar 2025; status: completed.
02
Drugs
elismetrep
03
Conditions
migraine
Beyond the preview
Go deeper on NCT06848075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06848075.